Deoxyribose wrote:
呵呵, 我一開始早就(恕刪)



啊...看你說得很高興,不小心睡著了
我懂,我對
覺得有錯,指證我錯就好
如同先前我忘了說過的話
該我的,我不會否認
反正你沒說我錯,那還有啥好質疑的?
而且也只有你有問題啊
然後你承認有病又不醫,所以你的問題沒人幫的了

所以
就看你哪時候提出我有錯的指證囉

Deoxyribose wrote:
台灣爆發了嗎?
Ramsa wrote:
所以相信你也知道後來美國CDC並沒有因為不準確
而將抗體檢測排除於檢測方式之外
相反的,還提出補強,建議抗體檢測要檢測2次以上,以提高準確性
認錯,是啦
但是美國CDC有提出相應的對策
而不是直接把抗體檢測排除在外
jerry2529 wrote:
請問你是否有證據支持「現在」的美國CDC仍在用「自己承認不準確的抗體檢測」當作確診的依據?
Ramsa wrote:下面擷取部分被你遺漏的內容,直接用google翻譯
https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-professional.html
5/28發布的,比5/23還晚一點
Antibody tests can support the clinical assessment of COVID-19 illness for people who are being tested 9 to 14 days after illness onset, in addition to recommended virus detection methods such as PCR. This will maximize sensitivity as the sensitivity of nucleic acid detection is decreasing and serologic testing is increasing during this time period.
Minimize false positive results by choosing an antibody test with high specificity and by testing populations and people who are likely to have had COVID-19. When testing people who live in an area where not many people have had COVID-19, consider using a second antibody test in addition to the first to better understand whether the initial result may have been a false positive.
表示美國CDC是持續優化抗體檢測的可信度,而不是屏除不用
jerry2529 wrote:
只看到美國CDC再次呼籲抗體測試結果不得用於診斷患有活動性感染的人
Ramsa wrote:
當你看了前面不得之後,但CDC在後面又有增加附帶說明,不知你有沒有看
CDC指出抗體檢測可適用範圍
而且 active infection 開放性感染 指的是評估傳染力
而不是評估有沒有確診
jerry2529 wrote:
美國CDC在2020(恕刪)